Skip to Content
Merck
CN

A convergent stereocontrolled total synthesis of (-)-terpestacin.

Organic & biomolecular chemistry (2012-06-20)
Yehua Jin, Fayang G Qiu
ABSTRACT

A stereocontrolled total synthesis of (-)-terpestacin has been achieved starting from (R)-(-)-carvone as a chiral pool and (E,E)-farnesol via a highly convergent approach. Thus, (R)-(-)-carvone was transformed into the cyclopentanone segment through a series of high yielding operations with the proper setup of all the stereochemical centers while (E,E)-farnesol was converted into the other requisite building block via a series of high yielding reactions. The cyclopentanone intermediate was both selectively enolized and alkylated at room temperature to yield the desired coupling product, which provided the natural product upon further transformations.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Carvone, ≥97%, FCC, FG
Sigma-Aldrich
L-Carvone, natural, 99%, FG
Sigma-Aldrich
D-Carvone, ≥96%, FG
Supelco
(+)-Carvone, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Farnesol, mixture of isomers, ≥95%, stabilized, FG
Sigma-Aldrich
(S)-(+)-Carvone, 96%
Sigma-Aldrich
Cyclopentanone, ReagentPlus®, ≥99%
Supelco
(+)-Carvone, analytical standard
Supelco
Cyclopentanone, analytical standard
Sigma-Aldrich
Farnesol, 95%
Supelco
(−)-Carvone, analytical standard
Sigma-Aldrich
(R)-(−)-Carvone, 98%
Sigma-Aldrich
Cyclopentanone, ≥99%, FG